<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680351</url>
  </required_header>
  <id_info>
    <org_study_id>49RC20_0270</org_study_id>
    <nct_id>NCT04680351</nct_id>
  </id_info>
  <brief_title>Evaluation of the Hemodynamic Effects of Transvenous Phrenic Stimulation</brief_title>
  <acronym>HEMOSTIM</acronym>
  <official_title>Evaluation of the Hemodynamic Effects of Transvenous Phrenic Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mechanical ventilation is a cornerstone in the management of severe forms of pneumonia, acute&#xD;
      respiratory distress syndrome. It provides essential oxygen to patients, ventilates the lungs&#xD;
      but also has deleterious effects like any treatment, in particular by reducing cardiac output&#xD;
      by reducing venous return. Mechanical ventilation also has effects on the diaphragm:&#xD;
      diaphragmatic dysfunction. It is explained by a prolonged inactivity of this muscle with a&#xD;
      reduction of muscle fibers that can settle down quickly, after only a few days of mechanical&#xD;
      ventilation. This dysfunction results in a reduction in the latter's ability to generate&#xD;
      intrathoracic pressure necessary for ventilation, slows the withdrawal of mechanical&#xD;
      ventilation and lengthens the duration of stay in intensive care unit. To reduce this&#xD;
      dysfunction, phrenic stimulation has been proposed as an alternative to remuscler the&#xD;
      diaphragm thanks to electrodes located on a central venous catheter, also used to deliver the&#xD;
      usual therapies in intensive care unit.&#xD;
&#xD;
      The HEMOSTIM study is interested in the effects of phrenic stimulation on regional&#xD;
      ventilation, cardiac output and cerebral perfusion: investigator hypothesize that&#xD;
      diaphragmatic stimulation allows an improvement of these parameters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of integral time speed by cardiac transthoracic ultrasound</measure>
    <time_frame>1 minute</time_frame>
    <description>to assess the effects of phrenic stimulation on cardiac output</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of increased venous return gradient in percentage (variation between the value before phrenic stimulation and the value after phrenic stimulation)</measure>
    <time_frame>1 minute</time_frame>
    <description>To specify the mechanisms of the effect of phrenic stimulation on cardiac output</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>variation in ventilation distribution before and after phrenic stimulation measured in electrical impedance tomography</measure>
    <time_frame>1 minute</time_frame>
    <description>To assess the effects of diaphragmatic stimulation on ventilation and pulmonary recruitment measured in electrical impedance tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of diaphragmatic stimulation on cerebral oxygenation evaluated by the Near infrared spectrometry technique</measure>
    <time_frame>1 minute</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>phrenic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phrenic stimulation</intervention_name>
    <description>measurements of the hemodynamic effects of phrenic stimulation</description>
    <arm_group_label>phrenic stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient included in RESCUE 3 study, interventional arm with phrenic stimulation&#xD;
&#xD;
          -  Patient or family consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient not affiliated or not benefiting from a social security scheme&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marie LEMERLE</last_name>
    <phone>0241353637</phone>
    <email>marie.lemerle@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DRCI Promotion Interne</last_name>
    <phone>0241353637</phone>
    <email>DRCI-Promotion-Interne@chu-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marie LEMERLE</last_name>
      <email>marie.lermerle@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP La Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandra BEURTON</last_name>
      <email>alexandra.beurton@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP La Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Martin DRES</last_name>
      <email>martin.dres@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

